Mostrando 4 resultados de: 4
Filtros aplicados
Subtipo de publicación
Article(4)
Publisher
Clinical Lymphoma, Myeloma and Leukemia(1)
Current Problems in Cancer(1)
JCO Global Oncology(1)
Medicine and Pharmacy Reports(1)
Área temáticas
Enfermedades(3)
Farmacología y terapéutica(2)
Medicina y salud(2)
Edificios residenciales y afines(1)
Problemas sociales y servicios a grupos(1)
Área de conocimiento
Medicina interna(1)
Origen
scopus(4)
Comparative survival analysis using the International Stratification Score (ISS) in newlydiagnosed multiple myeloma in the Uruguayan population
ArticleAbstract: Background and aims. Multiple myeloma is a frequent hematologic malignancy, in which the InternationPalabras claves:Multiple myeloma, survival analysis, URUGUAYAutores:Bove V., David Garrido, Matosas V., Riva E.Fuentes:scopusAnalysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries
ArticleAbstract: Latin American countries represents a large fraction of patients who are treated for multiple myelomPalabras claves:ACCESS, Health care systems, Latin America Countries, Multiple myeloma, New agentsAutores:Bujan W., Conte G., Crusoe E., Durie B., Espino G., Fantl D., Garcia D.K., Harousseau J.L., Hungria V.T.d.M., Jose Willian Oliveros Alvear, Lopez Dopico J.L., Macias J., Maiolino A., Navarro Cabrera J.R., Neves L.A., Ortiz D.R., Pessoa de Magalhães Filho R.J., Riva E., Royg M., Ruiz-Arguelles G.J., Socarra Z., Vega G.Q.Fuentes:scopusReal-world data on adult t-cell leukemia/lymphoma in latin america: A study from the grupo de estudio latinoamericano de linfoproliferativos
ArticleAbstract: PURPOSE Adult T-cell leukemia/lymphoma (ATLL) is an aggressive disease caused by the human T-cell lePalabras claves:Autores:Aguirre-Martinez L., Altamirano M., Aviles-Perez U., Beltran B.E., Biglione M., Cabrera M.E., Candelaria M., Castillo J.J., Castro D.A., Choque J.A., Cristaldo N., Enriquez D.J., Fiad L., Guanchiale L., Idrobo H., Malpica L., Maradei J.L., Marcos Di Stefano, Meza K., Noboa A., Otero V., Paredes S.R., Peña C., Prates M., Ramos J.C., Riva E., Sandival-Ampuero G., Soto P., Torres-Viera M.A., Valvert F., Villela L., Viñuela J.L., Von Glasenapp A.Fuentes:scopusSurvival analysis of transplant-eligible newly-diagnosed multiple myeloma patients harboring t(4;14), t(14;16), and/or del(17p) in the real-world setting
ArticleAbstract: Cytogenetic abnormalities (CA) such as t(4;14), t(14;16), and del(17p), are associated with a poor pPalabras claves:Chromosome aberrations, Hematopoietic stem cell transplantation, Multiple myeloma, SurvivalAutores:Abello V., Aranda S., Beltrán C., Bove V., Cantero-Fortiz Y., Cantú-Martínez O., Cardemil D., Cardenas K.M.G., Chandía M., Contreras C., Corzo A., Cruz-Mora A., David Garrido, Donoso J., Duarte P.J., Espinoza M., Fantl D., Fernández V., García C., García-Navarrete Y.I., Gaviria L., Gazitúa R., Gomez R., Gómez-Almaguer D., Henao-Uribe A., Hopkins C.R., Idrobo H., La Rocca G., León P., López-Vidal H., Lopresti S., Mantilla W., Martínez-Cordero H., Mite A., Molina A., Ochoa P., Orlando S., Osorio R., Osuna M., Pacheco M., Peña C., Quintero G., Quiroga L., Ramírez F., Ramirez J., Remaggi G., Reyes I., Riva E., Roa M., Ruiz-Argüelles G.J., Saavedra D., Sabando B., Schulz J., Schutz N., Shanley C., Slavutsky I., Sossa C., Soto P., Tarín-Arzaga L., Torres V., Verduga A., Vergara C.G., Verri V., Yantorno S., Zabaljauregui S.Fuentes:scopus